Strides Brings in Ascent Capital to Drive Next Phase of Growth for Pivot Path
MM Desk
13 July, 2026
Strides Pharma Science Limited (BSE: 532531, NSE: STAR) has announced a strategic investment in its
Strides Pharma Science Limited (BSE: 532531, NSE: STAR) has announced a strategic investment in its
Strides Pharma Science Limited has announced that its step-down subsidiary, Strides Pharma International AG, has
Strides Pharma, on Wednesday, announced its fiscal fourth-quarter results, showcasing robust performance with a significant